Results 171 to 180 of about 29,885 (192)

β‑Arrestin-Mediated Activation of Chemokine Receptor CCR7 by Human β‑Defensin‑3 Drives Oral Squamous Cell Carcinoma Progression. [PDF]

JACS Au
Kinanti NP, Chang CC, Lai XY, Hsu HJ.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Membrane phosphoinositides regulate GPCR-β-arrestin complex assembly and dynamics

Cell, 2022
John Janetzko, Brian K Kobilka
exaly  

GPCR-mediated β-arrestin activation deconvoluted with single-molecule precision

Cell, 2022
Wesley B Asher, Daniel S Terry, Alem W Kahsai   +2 more
exaly  

Plasma membrane preassociation drives β-arrestin coupling to receptors and activation

Cell, 2023
Maria Makarova, Davide Calebiro
exaly  

Receptor-Arrestin Interactions: The GPCR Perspective

Biomolecules, 2021
Mohammad Seyedabadi, Eugenia V Gurevich, Vsevolod V Gurevich   +2 more
exaly  

Cannabinoid 1 (CB1) receptor arrestin subtype‐selectivity and phosphorylation dependence

British Journal of Pharmacology, 2023
Jamie J Manning, Gabriel Rawcliffe, David B Finlay   +2 more
exaly  

β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors

Cell, 2020
Lauren M Slosky, Yushi Bai, Krisztián Tóth   +2 more
exaly  

Identification of Phosphorylation Codes for Arrestin Recruitment by G Protein-Coupled Receptors

Cell, 2017
X Edward Zhou, Yuanzheng He, Parker W de Waal   +2 more
exaly  

β-Arrestin-2 BRET Biosensors Detect Different β-Arrestin-2 Conformations in Interaction with GPCRs

ACS Sensors, 2020
Atsuro Oishi, Julie Dam, Ralf Jockers
exaly